Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Ward

Showing results (151-160 of 562) with videos related to

Pageof 57
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1975
A unique complement derived chemotactic factor for tumor cellsA G Romualdez, P A Ward
Progress in Clinical and Biological Research|January 1, 1976
Further studies on the C5-derived chemotactic factor for tumor cellsA G Romualdez, P A Ward
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Regulation of MIF by a factor in human serumP A Ward, R E Rocklin
Advances in Pharmacology (San Diego, Calif.)|January 1, 1993
Molecular mechanisms in acute lung injuryP A Ward, M S Mulligan
Current Opinion in Immunology|October 1, 1989
The acute inflammatory reactionP A Ward, R M Marks
Reviews of Physiology, Biochemistry and Pharmacology|January 1, 1977
Biology of leukotaxisP A Ward, E L Becker
JAMA|October 31, 1977
Immunopathology. Hypersensitivity or tolerance?T J Gill, P A Ward
Anaesthesia|September 7, 2022
Videolaryngoscopy: less 'looking round the corner'...more seeing what is in plain viewJ C Sturrock, P A Ward
Immunopharmacology|November 1, 1990
Structural requirements for binding of adenosine-5'-O-(3-thiotriphosphate) (ATP gamma S) to human neutrophilsG H Yu, P A Ward
The New England Journal of Medicine|January 10, 1974
Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivatorP A Ward, J L Berenberg
Pageof 57

Showing results (151-160 of 562) with videos related to

Sort By:
Pageof 57
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1975
A unique complement derived chemotactic factor for tumor cellsA G Romualdez, P A Ward
Progress in Clinical and Biological Research|January 1, 1976
Further studies on the C5-derived chemotactic factor for tumor cellsA G Romualdez, P A Ward
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1975
Regulation of MIF by a factor in human serumP A Ward, R E Rocklin
Advances in Pharmacology (San Diego, Calif.)|January 1, 1993
Molecular mechanisms in acute lung injuryP A Ward, M S Mulligan
Current Opinion in Immunology|October 1, 1989
The acute inflammatory reactionP A Ward, R M Marks
Reviews of Physiology, Biochemistry and Pharmacology|January 1, 1977
Biology of leukotaxisP A Ward, E L Becker
JAMA|October 31, 1977
Immunopathology. Hypersensitivity or tolerance?T J Gill, P A Ward
Anaesthesia|September 7, 2022
Videolaryngoscopy: less 'looking round the corner'...more seeing what is in plain viewJ C Sturrock, P A Ward
Immunopharmacology|November 1, 1990
Structural requirements for binding of adenosine-5'-O-(3-thiotriphosphate) (ATP gamma S) to human neutrophilsG H Yu, P A Ward
The New England Journal of Medicine|January 10, 1974
Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivatorP A Ward, J L Berenberg
Pageof 57